Two-Year Results From CLARITY Study With Cladribine Tablets In Multiple Sclerosis Published In The New England Journal Of Medicine
GENEVA, Switzerland, January 21 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the online publication of the results from the CLARITY(1) Phase III trial…